ENTITY

Homology Medicines Inc (FIXX US)

3
Analysis
Health CareUnited States
Homology Medicines, Inc. operates as a genetic medicines company. The Company offers a platform to utilize human hematopoietic stem cell derived adeno-associated virus vectors to treat a range of disease-causing mutations through gene correction, insertion, and knockout. Homology Medicines serves patients in the United States.
more
15 Apr 2026 19:42Primer

Primer: Homology Medicines Inc (FIXX US) - Apr 2026

Merger and Strategic Shift: Homology Medicines Inc. (formerly FIXX US) has ceased to exist as an independent entity following its merger with...

Logo
αSK
95 Views
Share
24 Apr 2024 18:56Syndicated

Homology Medicines Inc (FIXX) - Wednesday, Jan 24, 2024

Homology Medicines is undergoing a reverse merger with an inflammation and immunology company, providing investors with a valuable contingent value...

Share
26 Jan 2024 06:53Syndicated

Quick Ideas #7

A terrible reverse merger was inflicted on FIXX shareholders, and I was hoping the deal would be changed or some activist shareholder would jump in.

Share
No more insights
x